[HTML][HTML] NF-κB Pathway and Its Inhibitors: A Promising Frontier in the Management of Alzheimer's Disease
The nuclear factor kappa B (NF-κB) pathway has emerged as a pivotal player in the
pathogenesis of various diseases, including neurodegenerative illnesses like Alzheimer's …
pathogenesis of various diseases, including neurodegenerative illnesses like Alzheimer's …
[HTML][HTML] Computer-aided drug design towards new psychotropic and neurological drugs
Central nervous system (CNS) disorders are a therapeutic area in drug discovery where
demand for new treatments greatly exceeds approved treatment options. This is complicated …
demand for new treatments greatly exceeds approved treatment options. This is complicated …
Polypharmacological Potential of Phosphodiesterase 5 Inhibitors for the Treatment of Neurocognitive Disorders.
A Kumar, F Kim, DK Song, JJ Choung - Aging & Disease, 2023 - search.ebscohost.com
The prevalence of neurocognitive disorders (NCD) increases every year as the population
continues to age, leading to significant global health concerns. Overcoming this challenge …
continues to age, leading to significant global health concerns. Overcoming this challenge …
Effect of PDE 5 Inhibitor-Avanafil on Renal Ischemia/Reperfusion Injury in Rats.
Aim: Renal ischemia-reperfusion injury (RI/RI) damages many organs, especially the kidney.
Phosphodiesterase (PDE) 5 inhibitors has antioxidant and anti-inflammatory effects. Avanafil …
Phosphodiesterase (PDE) 5 inhibitors has antioxidant and anti-inflammatory effects. Avanafil …
[HTML][HTML] Sıçanlarda Renal İskemi/Reperfüzyon Hasarı Üzerine PDE 5 İnhibitörü-Avanafilin Etkisi
TN YÜKSEL, Z HALICI, K Cihangir, A BOZKURT… - 2023 - namikkemalmedj.com
Amaç: Renal iskemi-reperfüzyon hasarı (RI/RI) başta böbrek olmak üzere birçok organa
zarar verir. Fosfodiesteraz (PDE) 5 inhibitörleri, antioksidan ve anti-enflamatuvar etkilere …
zarar verir. Fosfodiesteraz (PDE) 5 inhibitörleri, antioksidan ve anti-enflamatuvar etkilere …